€112M Fund Launched to Commercialize UCL’s Gene Therapy Research
The leading UK institution University College London and the firm AlbionVC have made the first…
August 6, 2020 - 2 minutes
The leading UK institution University College London and the firm AlbionVC have made the first…
Basel-based T3 Pharmaceuticals has closed its third financing round, worth over €23.3M (CHF 25M), to…
Hansa Biopharma has granted an exclusive license to Sarepta Therapeutics for developing and promoting a…